These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 23661553)

  • 21. Enhanced hepatocyte growth factor signaling by type II transforming growth factor-beta receptor knockout fibroblasts promotes mammary tumorigenesis.
    Cheng N; Chytil A; Shyr Y; Joly A; Moses HL
    Cancer Res; 2007 May; 67(10):4869-77. PubMed ID: 17495323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TGF-β (Transforming Growth Factor-β) Signaling Protects the Thoracic and Abdominal Aorta From Angiotensin II-Induced Pathology by Distinct Mechanisms.
    Angelov SN; Hu JH; Wei H; Airhart N; Shi M; Dichek DA
    Arterioscler Thromb Vasc Biol; 2017 Nov; 37(11):2102-2113. PubMed ID: 28729364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TGFβ signaling limits lineage plasticity in prostate cancer.
    Hao Y; Bjerke GA; Pietrzak K; Melhuish TA; Han Y; Turner SD; Frierson HF; Wotton D
    PLoS Genet; 2018 May; 14(5):e1007409. PubMed ID: 29782499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TGFβ signaling in myeloid cells regulates mammary carcinoma cell invasion through fibroblast interactions.
    Shaw AK; Pickup MW; Chytil A; Aakre M; Owens P; Moses HL; Novitskiy SV
    PLoS One; 2015; 10(1):e0117908. PubMed ID: 25629162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TGF-β-responsive myeloid cells suppress type 2 immunity and emphysematous pathology after hookworm infection.
    Heitmann L; Rani R; Dawson L; Perkins C; Yang Y; Downey J; Hölscher C; Herbert DR
    Am J Pathol; 2012 Sep; 181(3):897-906. PubMed ID: 22901754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transforming growth factor-beta signaling-deficient fibroblasts enhance hepatocyte growth factor signaling in mammary carcinoma cells to promote scattering and invasion.
    Cheng N; Chytil A; Shyr Y; Joly A; Moses HL
    Mol Cancer Res; 2008 Oct; 6(10):1521-33. PubMed ID: 18922968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic targeting of the focal adhesion complex prevents oncogenic TGF-beta signaling and metastasis.
    Wendt MK; Schiemann WP
    Breast Cancer Res; 2009; 11(5):R68. PubMed ID: 19740433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostate tumor progression is mediated by a paracrine TGF-beta/Wnt3a signaling axis.
    Li X; Placencio V; Iturregui JM; Uwamariya C; Sharif-Afshar AR; Koyama T; Hayward SW; Bhowmick NA
    Oncogene; 2008 Nov; 27(56):7118-30. PubMed ID: 18724388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inactivation of TGF-beta signaling in hepatocytes results in an increased proliferative response after partial hepatectomy.
    Romero-Gallo J; Sozmen EG; Chytil A; Russell WE; Whitehead R; Parks WT; Holdren MS; Her MF; Gautam S; Magnuson M; Moses HL; Grady WM
    Oncogene; 2005 Apr; 24(18):3028-41. PubMed ID: 15735717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of T cell TGF-beta signaling in intestinal cytokine responses and helminthic immune modulation.
    Ince MN; Elliott DE; Setiawan T; Metwali A; Blum A; Chen HL; Urban JF; Flavell RA; Weinstock JV
    Eur J Immunol; 2009 Jul; 39(7):1870-8. PubMed ID: 19544487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. USP8 promotes cancer progression and extracellular vesicle-mediated CD8+ T cell exhaustion by deubiquitinating the TGF-β receptor TβRII.
    Xie F; Zhou X; Li H; Su P; Liu S; Li R; Zou J; Wei X; Pan C; Zhang Z; Zheng M; Liu Z; Meng X; Ovaa H; Ten Dijke P; Zhou F; Zhang L
    EMBO J; 2022 Aug; 41(16):e108791. PubMed ID: 35811497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progression of human bronchioloalveolar carcinoma to invasive adenocarcinoma is modeled in a transgenic mouse model of K-ras-induced lung cancer by loss of the TGF-β type II receptor.
    Borczuk AC; Sole M; Lu P; Chen J; Wilgus ML; Friedman RA; Albelda SM; Powell CA
    Cancer Res; 2011 Nov; 71(21):6665-75. PubMed ID: 21911454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-beta signaling in cooperation with active Kras expression.
    Ijichi H; Chytil A; Gorska AE; Aakre ME; Fujitani Y; Fujitani S; Wright CV; Moses HL
    Genes Dev; 2006 Nov; 20(22):3147-60. PubMed ID: 17114585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AKT hyperactivation confers a Th1 phenotype in thymic Treg cells deficient in TGF-β receptor II signaling.
    Liu Y; Xu Y; Sun J; Ma A; Zhang F; Xia S; Xu G; Liu Y
    Eur J Immunol; 2014 Feb; 44(2):521-32. PubMed ID: 24165986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of TGF-β signaling in osteoblasts increases basic-FGF and promotes prostate cancer bone metastasis.
    Meng X; Vander Ark A; Daft P; Woodford E; Wang J; Madaj Z; Li X
    Cancer Lett; 2018 Apr; 418():109-118. PubMed ID: 29337106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transforming growth factor beta-induced Smad1/5 phosphorylation in epithelial cells is mediated by novel receptor complexes and is essential for anchorage-independent growth.
    Daly AC; Randall RA; Hill CS
    Mol Cell Biol; 2008 Nov; 28(22):6889-902. PubMed ID: 18794361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TGF-β receptor II loss promotes mammary carcinoma progression by Th17 dependent mechanisms.
    Novitskiy SV; Pickup MW; Gorska AE; Owens P; Chytil A; Aakre M; Wu H; Shyr Y; Moses HL
    Cancer Discov; 2011 Oct; 1(5):430-41. PubMed ID: 22408746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of noncanonical TGF-β signaling prevents cleft palate in Tgfbr2 mutant mice.
    Iwata J; Hacia JG; Suzuki A; Sanchez-Lara PA; Urata M; Chai Y
    J Clin Invest; 2012 Mar; 122(3):873-85. PubMed ID: 22326956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development.
    Yin JJ; Selander K; Chirgwin JM; Dallas M; Grubbs BG; Wieser R; Massagué J; Mundy GR; Guise TA
    J Clin Invest; 1999 Jan; 103(2):197-206. PubMed ID: 9916131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Defective TGF-β signaling in bone marrow-derived cells prevents hedgehog-induced skin tumors.
    Fan Q; Gu D; Liu H; Yang L; Zhang X; Yoder MC; Kaplan MH; Xie J
    Cancer Res; 2014 Jan; 74(2):471-483. PubMed ID: 24282281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.